Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2368233
Max Phase: Preclinical
Molecular Formula: C49H73NO15
Molecular Weight: 916.12
Molecule Type: Small molecule
Associated Items:
ID: ALA2368233
Max Phase: Preclinical
Molecular Formula: C49H73NO15
Molecular Weight: 916.12
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@@H](OC)[C@@H](O[C@H]4C[C@@H](OC)[C@@H](OC(N)=O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2
Standard InChI: InChI=1S/C49H73NO15/c1-11-25(2)42-28(5)17-18-48(65-42)23-34-20-33(64-48)16-15-27(4)41(26(3)13-12-14-32-24-57-45-40(51)29(6)19-35(46(52)60-34)49(32,45)54)61-38-21-36(55-9)43(30(7)58-38)62-39-22-37(56-10)44(31(8)59-39)63-47(50)53/h12-15,17-19,25-26,28,30-31,33-45,51,54H,11,16,20-24H2,1-10H3,(H2,50,53)/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36+,37+,38-,39-,40+,41-,42+,43-,44-,45+,48+,49+/m0/s1
Standard InChI Key: CSLPBJDVEWUTKI-GZWVGPPUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 916.12 | Molecular Weight (Monoisotopic): 915.4980 | AlogP: 5.48 | #Rotatable Bonds: 9 |
Polar Surface Area: 202.15 | Molecular Species: NEUTRAL | HBA: 15 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.55 | CX Basic pKa: | CX LogP: 5.96 | CX LogD: 5.96 |
Aromatic Rings: 0 | Heavy Atoms: 65 | QED Weighted: 0.19 | Np Likeness Score: 2.26 |
1. Mrozik H, Eskola P, Fisher MH, Egerton JR, Cifelli S, Ostlind DA.. (1982) Avermectin acyl derivatives with anthelmintic activity., 25 (6): [PMID:7097720] [10.1021/jm00348a010] |
Source(1):